跳至主要内容
临床试验/JPRN-jRCTs032190180
JPRN-jRCTs032190180暂停1 期

A Phase I/II trial of radical carbon-ion radiotherapy using 4 fractions for the patients with high-risk prostate cancer and urethral dose measurement

Tsuji Hiroshi0 个研究点目标入组 40 人开始时间: 2020年1月9日最近更新:
适应症

试验速览

阶段
1 期
状态
暂停
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
Male

入选标准

  • 1) biopsy-proven prostate cancer, 2) age >20 years, 3) T3a-T4N0M0 or PSA >= 20 ng/ml, GS>=8 according to MRI, CT and bone scintigram 4) Performance Status (ECOG), 0-1 5) Expected prognosis > 6 months 6) ability to understand and sign an informed consent form at each institution.

排除标准

  • 1) Other therapies except for hormonal therapy
  • 2) Previous radiation therapy to the pelvis
  • 3) Significant excess over the dose-constraints for risk organs
  • 4) Castration-resistant prostate cancer
  • 5) Previous treatment history of TUR-P
  • 6) Active Double cancer
  • 7) Untreatable infection or inflammatory disease in pelvis.
  • 8) a serious medical or psychological condition precluding safe administration of treatment

研究者

发起方
Tsuji Hiroshi

相似试验